The site is undergoing maintenance. Ordering can continue through fax and phone.
Sunday, August 16, 2026, 1:30 - 4:30 pm (SAST).
If you encounter problems while ordering. Please contact us at BDBCustomerService@bd.com
See MoreYour selected location is
Middle East / Africa
The site is undergoing maintenance. Ordering can continue through fax and phone.
Sunday, August 16, 2026, 1:30 - 4:30 pm (SAST).
If you encounter problems while ordering. Please contact us at BDBCustomerService@bd.com
See MoreThe site is undergoing maintenance. Ordering can continue through fax and phone.
Sunday, August 16, 2026, 1:30 - 4:30 pm (SAST)
.If you encounter problems while ordering. Please contact us at BDBCustomerService@bd.com
This page has been recently translated and is available in French now.
Looks like you're visiting us from {countryName}.
Would you like to stay on the current location site or be switched to your location?
Flow cytometric analysis of Siglec-1 (CD169) expression on fresh or Interferon-α (IFN-α)-treated human peripheral blood mononuclear cells. Fresh human PBMC (Top Panels) or PBMC cultured with recombinant human IFN-α2a protein (20 ng/mL) for 48 hoursor (Bottom Panels) were prepared. The cells were washed, preincubated with BD Pharmingen™ Human BD Fc Block™ (Cat. No. 564219/564220), and stained with PE Mouse Anti-Human CD14 antibody (Cat. No. 555398/557154/561707) and either Alexa Fluor® 647 Mouse IgG1, κ Isotype Control (Cat. No. 557714; Left Panels) or Alexa Fluor® 647 Mouse Anti-Human Siglec-1 (CD169) antibody (Cat. No. 565295; Right Panels). Two-color flow cytometric contour plots showing the correlated expression of Siglec-1 (CD169) (or Ig Isotype control staining) versus CD14 were derived from gated events with the forward and side light-scatter characteristics of viable mononuclear cells. Flow cytometric analysis was performed using a BD LSRFortessa™ Cell Analyzer System.
Flow cytometric analysis of Siglec-1 (CD169) expression on fresh or Interferon-α (IFN-α)-treated human peripheral blood mononuclear cells. Fresh human PBMC (Top Panels) or PBMC cultured with recombinant human IFN-α2a protein (20 ng/mL) for 48 hoursor (Bottom Panels) were prepared. The cells were washed, preincubated with BD Pharmingen™ Human BD Fc Block™ (Cat. No. 564219/564220), and stained with PE Mouse Anti-Human CD14 antibody (Cat. No. 555398/557154/561707) and either Alexa Fluor® 647 Mouse IgG1, κ Isotype Control (Cat. No. 557714; Left Panels) or Alexa Fluor® 647 Mouse Anti-Human Siglec-1 (CD169) antibody (Cat. No. 565295; Right Panels). Two-color flow cytometric contour plots showing the correlated expression of Siglec-1 (CD169) (or Ig Isotype control staining) versus CD14 were derived from gated events with the forward and side light-scatter characteristics of viable mononuclear cells. Flow cytometric analysis was performed using a BD LSRFortessa™ Cell Analyzer System.
Flow cytometric analysis of Siglec-1 (CD169) expression on fresh or Interferon-α (IFN-α)-treated human peripheral blood mononuclear cells. Fresh human PBMC (Top Panels) or PBMC cultured with recombinant human IFN-α2a protein (20 ng/mL) for 48 hoursor (Bottom Panels) were prepared. The cells were washed, preincubated with BD Pharmingen™ Human BD Fc Block™ (Cat. No. 564219/564220), and stained with PE Mouse Anti-Human CD14 antibody (Cat. No. 555398/557154/561707) and either Alexa Fluor® 647 Mouse IgG1, κ Isotype Control (Cat. No. 557714; Left Panels) or Alexa Fluor® 647 Mouse Anti-Human Siglec-1 (CD169) antibody (Cat. No. 565295; Right Panels). Two-color flow cytometric contour plots showing the correlated expression of Siglec-1 (CD169) (or Ig Isotype control staining) versus CD14 were derived from gated events with the forward and side light-scatter characteristics of viable mononuclear cells. Flow cytometric analysis was performed using a BD LSRFortessa™ Cell Analyzer System.
Flow cytometric analysis of Siglec-1 (CD169) expression on fresh or Interferon-α (IFN-α)-treated human peripheral blood mononuclear cells. Fresh human PBMC (Top Panels) or PBMC cultured with recombinant human IFN-α2a protein (20 ng/mL) for 48 hoursor (Bottom Panels) were prepared. The cells were washed, preincubated with BD Pharmingen™ Human BD Fc Block™ (Cat. No. 564219/564220), and stained with PE Mouse Anti-Human CD14 antibody (Cat. No. 555398/557154/561707) and either Alexa Fluor® 647 Mouse IgG1, κ Isotype Control (Cat. No. 557714; Left Panels) or Alexa Fluor® 647 Mouse Anti-Human Siglec-1 (CD169) antibody (Cat. No. 565295; Right Panels). Two-color flow cytometric contour plots showing the correlated expression of Siglec-1 (CD169) (or Ig Isotype control staining) versus CD14 were derived from gated events with the forward and side light-scatter characteristics of viable mononuclear cells. Flow cytometric analysis was performed using a BD LSRFortessa™ Cell Analyzer System.
Flow cytometric analysis of Siglec-1 (CD169) expression on fresh or Interferon-α (IFN-α)-treated human peripheral blood mononuclear cells. Fresh human PBMC (Top Panels) or PBMC cultured with recombinant human IFN-α2a protein (20 ng/mL) for 48 hoursor (Bottom Panels) were prepared. The cells were washed, preincubated with BD Pharmingen™ Human BD Fc Block™ (Cat. No. 564219/564220), and stained with PE Mouse Anti-Human CD14 antibody (Cat. No. 555398/557154/561707) and either Alexa Fluor® 647 Mouse IgG1, κ Isotype Control (Cat. No. 557714; Left Panels) or Alexa Fluor® 647 Mouse Anti-Human Siglec-1 (CD169) antibody (Cat. No. 565295; Right Panels). Two-color flow cytometric contour plots showing the correlated expression of Siglec-1 (CD169) (or Ig Isotype control staining) versus CD14 were derived from gated events with the forward and side light-scatter characteristics of viable mononuclear cells. Flow cytometric analysis was performed using a BD LSRFortessa™ Cell Analyzer System.
Flow cytometric analysis of Siglec-1 (CD169) expression on fresh or Interferon-α (IFN-α)-treated human peripheral blood mononuclear cells. Fresh human PBMC (Top Panels) or PBMC cultured with recombinant human IFN-α2a protein (20 ng/mL) for 48 hoursor (Bottom Panels) were prepared. The cells were washed, preincubated with BD Pharmingen™ Human BD Fc Block™ (Cat. No. 564219/564220), and stained with PE Mouse Anti-Human CD14 antibody (Cat. No. 555398/557154/561707) and either Alexa Fluor® 647 Mouse IgG1, κ Isotype Control (Cat. No. 557714; Left Panels) or Alexa Fluor® 647 Mouse Anti-Human Siglec-1 (CD169) antibody (Cat. No. 565295; Right Panels). Two-color flow cytometric contour plots showing the correlated expression of Siglec-1 (CD169) (or Ig Isotype control staining) versus CD14 were derived from gated events with the forward and side light-scatter characteristics of viable mononuclear cells. Flow cytometric analysis was performed using a BD LSRFortessa™ Cell Analyzer System.
Any use of products other than the permitted use without the express written authorization of Becton, Dickinson and Company is strictly prohibited.
The 7-239 monoclonal antibody specifically binds to Sialic acid-binding Ig-like lectin 1 (Siglec-1), which is also known as Sialoadhesin (SN), or CD169. Siglec-1 is a type I transmembrane glycoprotein that belongs to the Siglec family within the Ig superfamily. This adhesion molecule especially binds to glycolipids and glycoproteins with terminal α-2 sialyl residues. Siglec-1 is expressed by macrophages and dendritic cells and serves as a cellular interaction molecule. Its expression can be upregulated by cells in response to type II collagen, or to cytokines including interferons, and tumor necrosis factor. Siglec-1 plays roles in endocytosis, hematopoiesis, and leucocyte migration. It mediates macrophage binding to various cell types including developing and mature leucocytes. Siglec-1 that is expressed by dendritic cells can also bind HIV-1 and may mediate viral transfer to bystander CD4+ T cells. Several Siglec-1 counter-receptors have been described including CD43, CD206, and CD227 which are expressed by T cells, macrophages, or breast cancer cells, respectively. The 7-239 antibody reportedly blocks Siglec-1 functions in some cellular assay systems.
Please refer to Support Documents for Quality Certificates
Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described
Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.
For Research Use Only. Not for use in diagnostic or therapeutic procedures.